Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Pyridazine compounds for controlling invertebrate pests
Electronic apparatus and manufacturing method of electronic apparatus
Medical imaging probe with rotary encoder
Communications in an asynchronous cellular wireless network
Display screen with graphical user interface
Lookup front end packet input processor
Light-emitting device package structure
  Randomly Featured Patents
Formation of a field reversed configuration for magnetic and electrostatic confinement of plasma
Method and system for providing call screening in a packet-switched network
System to generate an aggregate interest indication with respect to an information item
Front cover for a handset
System for creating motion effects employing still projection equipment
Method for providing tap leakage in adaptive equalizer systems
Method and apparatus for reading data from mirrored logical volumes on physical disk drives
Bone fixation assembly
Monolithic optical assembly
Phase locked loop with high-speed locking characteristic